Inhibition of VEGFRs using either low molecular weight kinase inhibitors or specific VEGFR2 (but not VEGFR1) blocking antibodies was also sufficient to trigger alveolar apoptosis and development of emphysema in mice and rats14,15. The gene discussed is FLT1; the disease is pulmonary emphysema.